We have studied the brains of 10 patients with clinically and patholog
ically defined Huntington's disease and graded the degree of striatal
pathology according to the Vonsattel grading system. Sections from nin
e cerebral cortical areas (Brodmann areas 8, 10, 24, 33, 28, 38, 7, 39
, 18), the cerebellum, hypothalamus, medulla and caudate nucleus were
stained with antibodies to ubiquitin and ubiquitin C-terminal hydrolas
e (PGP 9.5). Dystrophic neurites, immunoreactive with ubiquitin and PG
P 9.5 were detected in all cortical areas, in layers 3, 5 and 6, of al
l brains studied. No dystrophic neurites were found in subcortical are
as or cerebellum. Sections from cortical areas 8 and 24 from the two b
rains with the most and least ubiquitin-immunoreactive neurites were s
tained with antibodies to beta-amyloid precursor protein, tau, glial f
ibrillary acidic protein, neurofilament protein, alpha B crystallin, G
ABA, cholecystokinin and somatostatin. The dystrophic neurites were fo
und to also react with P-amyloid precursor protein. Electron microscop
y showed the abnormal neurites to contain granulofilamentous material.
Granular deposits with a diameter of 40-100nm were interspersed betwe
en randomly orientated 'fuzzy' or coated, straight or slightly curved
filaments measuring 10-15 nm in diameter. These structures have not be
en seen in control brain and differ from age-related neuritic degenera
tion and neurites associated with amyloid. Immunohistochemically these
structures most resemble CA 2/3 neurites seen in Lewy body disease, a
nd, ultrastructurally, the intraneuronal filamentous inclusions in mot
or neuron disease. The areal density of these neurites was quantified
in 20 microscopic fields in the superior frontal and anterior cingulat
e sections (Brodmann areas 8 and 24) and did not correlate with the Vo
nsattel grade, suggesting that they are an independent and possibly pr
imary cortical pathology in Huntington's disease.